AT1 Medical

AT1 Medical is a medical technology company focused on personalizing the treatment of hypertension through precision diagnostics. The company is developing a proprietary point-of-care (POC) device that measures Angiotensin II levels in blood, allowing physicians to identify the specific drivers of a patient's high blood pressure. This approach enables the selection of the most effective antihypertensive medication, such as ACE inhibitors or Angiotensin Receptor Blockers (ARBs), based on individual biomarker data. By reducing the reliance on trial-and-error prescribing, AT1 Medical aims to improve patient outcomes and reduce the global burden of cardiovascular disease. The company is headquartered at Alderley Park in the United Kingdom.